NPPB and chronic obstructive pulmonary disease: Before considering a vasodilator therapy as a possible therapeutic strategy in COPD induced PH patients with high plasma NT-proBNP levels, additional data should be obtained from studies enrolling large number of patients but since PH is a relatively rare disease, it may not be feasible to power a clinical trial with a sufficient number of patients to effectively use these treatments.